<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Chem B</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Chem B</journal-id><journal-id journal-id-type="publisher-id">jp</journal-id><journal-id journal-id-type="coden">jpcbfk</journal-id><journal-title-group><journal-title>The Journal of Physical Chemistry. B</journal-title></journal-title-group><issn pub-type="ppub">1520-6106</issn><issn pub-type="epub">1520-5207</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25426702</article-id><article-id pub-id-type="pmc">4306489</article-id><article-id pub-id-type="doi">10.1021/jp508545d</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Why Bound Amantadine Fails
to Inhibit Proton Conductance
According to Simulations of the Drug-Resistant Influenza A M2 (S31N)</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Gleed</surname><given-names>Mitchell
L.</given-names></name></contrib><contrib contrib-type="author" corresp="yes" id="ath2"><name><surname>Busath</surname><given-names>David D.</given-names></name><xref rid="ath2" ref-type="other">*</xref></contrib><aff id="aff1">Department
of Physiology
and Developmental Biology, <institution>Brigham Young
University</institution>, Provo, Utah 84602, <country>United
States</country></aff></contrib-group><pub-date pub-type="pmc-release"><day>18</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>22</day><month>01</month><year>2015</year></pub-date><volume>119</volume><issue>3</issue><issue-title>William L. Jorgensen Festschrift</issue-title><fpage>1225</fpage><lpage>1231</lpage><history><date date-type="received"><day>23</day><month>08</month><year>2014</year></date><date date-type="rev-recd"><day>15</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 American
Chemical Society</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American
Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0008" id="ab-tgr1"/></p><p>The mechanisms responsible for drug
resistance in the Asn31 variant
of the M2 protein of influenza A are not well understood. Molecular
dynamics simulations were performed on wild-type (Ser31) and S31N
influenza A M2 in the homotetramer configuration. After evaluation
of 13 published M2 structures, a solid-state NMR structure with amantadine
bound was selected for simulations, an S31N mutant structure was developed
and equilibrated, and the native and mutant structures were used to
determine the binding behavior of amantadine and the dynamics of water
in the two channels. Amantadine is stable in the plugging region of
wild-type M2, with the adamantane in contact with the Val27 side chains,
while amantadine in S31N M2 has more variable movement and orientation,
and spontaneously moves lower into the central cavity of the channel.
Free energy profiles from umbrella sampling support this observation.
In this configuration, water surrounds the drug and can easily transport
protons past it, so the drug binds without blocking proton transport
in the S31N M2 channel.</p></abstract><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>jp508545d</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>jp-2014-08545d</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>The M2 proton channel
plays an important role in transporting protons,
both across the viral envelope and across the Golgi of the infected
cell in influenza A or B. The structure and dynamics of water molecules
in the channel is of fundamental importance for the transport of protons
through the channel. Blocking the M2 channel arrests these important
proton transport processes in the viral replication cycle and prevents
infection.</p><p>Drugs such as amantadine and rimantadine, which were
once effective
at treating influenza A, have become obsolete due to widespread resistance.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Influenza A with M2 featuring a mutation from
Ser31 to Asn31 (S31N) has become prevalent worldwide,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> and no effective anti-M2 influenza medication is currently
available for its treatment. Understanding why drugs lose efficacy
after viral mutation can help inspire changes to existing drugs or
lead to the invention of novel drugs adapted to existing and future
mutations.</p><p>Molecular modeling and dynamics simulations have
proven useful
in studying biological systems, and many studies have been performed
on M2 channels<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref6">6</xref></sup> and its inhibitors.<sup><xref ref-type="bibr" rid="ref7">7</xref>&#x02212;<xref ref-type="bibr" rid="ref10">10</xref></sup> Some of the most salient recent observations include the general
shape of the free energy profile for the passage of amantadine through
wild-type (WT) and V27A M2,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> the three
main amino positions observed for amine compounds in the WT channel,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> the C-ward amine configuration for amantadine
in the WT channel and N-ward isoxazole configuration for a novel S31N
M2 blocker in the S31N channel,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> and the
agreement with experimental efficacies for relative binding energies
calculated using free energy perturbation for a set of adamantane
compounds in WT and S31N M2 channels.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> The important roles of luminal water in the binding cavity have
been highlighted in these studies, all of which used TIP3P water to
maintain consistency with the protein, lipid, and ion force fields.
They all use 4-fold symmetric, homotetrameric M2-truncate structures.
However, they vary in the precise M2 structures, which have been determined
with different methods, at different temperatures, and in different
lipidic or detergent environments; and which vary in M2 His37 and
drug titration states. These important physical factors, among others
(presence or absence of counterions in the channel, structure of the
protein N- and C-termini, lipid characteristics, etc.), are still
poorly established and are currently in the process of evaluation.
Although recent FRET data indicate that the functional protein may
be dimeric in cells,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> we continue to focus
on the homotetrameric structure for this investigation to agree with
earlier structural<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> and functional studies.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref19">19</xref></sup> We describe our more comprehensive rationale for selection of the
other physical factors mentioned. This study aims to use molecular
dynamics simulations to compare binding behavior of amantadine when
positioned inside WT or the primary amantadine-insensitive M2 (S31N)
with the goal of identifying the mechanism of resistance.</p></sec><sec sec-type="methods" id="sec2"><title>Methodology</title><p>M2 channel structures used in the study were derived from the RCSB
Protein Data Bank. The homotetrameric protein was embedded in a membrane
(situated perpendicular to the <italic>z</italic> axis) comprised
of 96 1,2-dimyristoyl-<italic>sn</italic>-glycero-3-phosphocholine
(DMPC) lipid molecules to agree with the lipid used for most solid-state
NMR structure determinations. Periodic boundary conditions with unit
cells of about 60 &#x000d7; 60 &#x000d7; 90 &#x000c5;<sup>3</sup> in <italic>x</italic>, <italic>y</italic>, and <italic>z</italic> dimensions
were used for all systems, and TIP3P<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> water
molecules with &#x0223c;150 mM NaCl (net electroneutral system) encased
the bilayer. Molecular dynamics packages CHARMM37,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> NAMD 2.9,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> and VMD 1.9.1<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> were used for simulations and analysis, and
the CHARMM36 all-atom empirical force field was used, except as noted,
to describe proteins and lipids.<sup><xref ref-type="bibr" rid="ref24">24</xref>&#x02212;<xref ref-type="bibr" rid="ref28">28</xref></sup></p><p>Unless otherwise noted, all simulations were
performed with positively
charged amantadine and neutral His37 residues. Despite solid-state
NMR data that shows the p<italic>K</italic><sub>a</sub> for the His37
tetrad is near 8.0 for the first two His37 protonations,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> we reasoned that each His37 side chain would
be protonated only at the N&#x003b5; site under conditions of neutral
pH with positively charged amantadine bound.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> Although amantadine has a p<italic>K</italic><sub>a</sub> of 10.1
in aqueous solution and has been shown by solid-state NMR to be neutral
in the M2 channel at pH 8.0,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> we reasoned
that the p<italic>K</italic> shift expected upon binding in the low
dielectric region would probably not be sufficient to result in deprotonation
of the drug under neutral, or at least under acidic, conditions.</p><p>Using the Nos&#x000e9;&#x02013;Hoover Langevin piston pressure control<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> and Langevin dynamics, systems were kept, after initial heating,
near 1 atm isotropically (i.e., zero surface tension) and 310 K to
achieve the NPT ensemble. Long-range Coulombic interactions were calculated
using the particle mesh Ewald (PME) algorithm.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The Shake method<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> was used
to keep all bonds with hydrogen rigid at ideal lengths and angles,
and short-range electrostatic and van der Waals forces were smoothed
using a switching distance of 11 &#x000c5;.</p><sec id="sec2.1"><title>Channel Hydration and Initial
Equilibration</title><p>RCSB Protein
Data Bank structures 1NYJ,<sup><xref ref-type="bibr" rid="ref37">37</xref></sup>2H95,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup>2KAD,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup>2KIH,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup>2KIX,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup>2KQT,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup>2KWX,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup>2L0J,<sup><xref ref-type="bibr" rid="ref31">31</xref></sup>2LJB,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup>2LJC,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup>2LY0,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup>2RLF,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> and 3LBW(<xref ref-type="bibr" rid="ref16">16</xref>) were imported, residues beyond position
46 were truncated, and the transmembrane domains of the M2 channels
were embedded in DMPC lipid in water, as described previously. Multiple
phases of energy minimization with decreasing harmonic restraints
were performed to bring the systems toward an energy minimum under
the CHARMM force field. Following minimization, water molecules were
inserted into channel pores in either excess (overhydrated) or low
(underhydrated) amounts in separate systems to provide starting points
for water to begin equilibration. With the protein backbone lightly
restrained to the average backbone coordinates of each channel&#x02019;s
set of models (or, if the structure consists of just one model, to
the backbone of that model), the systems were equilibrated for 6 ns
without drug present to allow water to exit or fill the channel pore.
Varying random-number-generator seeds for initial velocity assignments
were used to produce three distinct runs of 6 ns each, which proved
to be sufficient time to essentially equilibrate the overfilled channels.
CHARMM was used to postprocess the trajectories for RMSD and water-content
calculations.</p></sec><sec id="sec2.2"><title>Unrestrained Dynamics of Drugged WT and S31N
Systems</title><p>The solid-state NMR amantadine-bound structure by
Cady et al., 2KQT, was ultimately
selected to model WT M2, and from the same structure, an S31N mutant
homology model was created with Swiss-PdbViewer,<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup> which was subsequently hydrated and equilibrated as performed for
the other channels. The M2 blocker, amantadine, was used in each system
to test for an aqueous path for proton conductance with drug present
for both WT and S31N M2 channels. Force field parameters for amantadine
were generated using adamantane parameters from the CHARMM general
force field (CGenFF) version 36<sup><xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> using ParamChem.<sup><xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>In the initial simulations with unrestrained drug molecules,
protonated or deprotonated amantadine molecules were added to previously
hydrated WT and S31N M2 channel systems. Drugs were inserted with
adamantane carbon atoms positioned &#x02265;2.2 &#x000c5; away (in the
C-terminal direction) from the Val27 side chain atoms and oriented
with the amino group pointing toward the C-terminus in order to agree
with previous findings.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> For electroneutrality,
a chloride ion (Cl<sup>&#x02013;</sup>) was added near the amine group
in systems with protonated drug. Water molecules within 2.2 &#x000c5;
of amantadine were deleted, and several rounds of energy minimization
were performed.</p><p>Each system was heated and equilibrated with
five different initial
random velocity sets and then independently simulated for 10.5 ns
with a time step of 1.5 fs, using NAMD. Following simulations, center-of-mass
positions were determined from the simulation trajectories, oriented
frame-wise to the protein backbone, using CHARMM. Two-dimensional
density profiles were produced using the VMD Density Profile Tool,<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> three-dimensional volume densities were calculated
using VMD&#x02019;s VolMap plugin, and volume-density maps were processed
from VolMap output using OpenDX.</p></sec><sec id="sec2.3"><title>Potential of Mean Force
Computation</title><p>Umbrella sampling
of protonated amantadine in hydrated WT and S31N M2 channels was carried
out using CHARMM37. A harmonic restraint of 0.1 kcal/mol-&#x000c5;<sup>2</sup> was applied to hold each protein backbone atom to the highly
colocalized protein backbone coordinates averaged over all 17 2KQT PDB models. These
channel backbone restraints allow only modest fluctuations of the
tetramer, such that the drug binding cavity is readily explored on
a short time scale, at the obvious cost of not fully simulating the
protein backbone mobility at each drug umbrella position. 2KQT was determined with
amantadine in the binding site. There, and at most other sites, where
the compound is smaller than the cavity, such fluctuations are not
expected to impact the free energy significantly. A <italic>z</italic>-dimensional harmonic restraint of 10 kcal/mol-&#x000c5;<sup>2</sup> was applied to the center of mass of the drug&#x02019;s adamantane
cage as an umbrella potential.</p><p>Langevin dynamics were used to
bring each system to 310 K, after which the Nos&#x000e9;&#x02013;Hoover
thermostat and the Verlet leapfrog algorithm<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> were used to equilibrate each system at constant pressure and temperature
for 1.5 ns with a 1.5 fs time step. The effects of initial amantadine
orientation were explored by inserting amantadine at each umbrella
window with its amine group oriented either toward the positive-<italic>z</italic> dimension or negative-<italic>z</italic> dimension along
the simulation <italic>z</italic> axis, after which any overlapping
water was removed. The preliminary studies showed that Cl<sup>&#x02013;</sup> would fit in the channel with amantadine, but we reasoned that the
probability of Cl<sup>&#x02013;</sup> being in the channel at the time
of amantadine entry, or entering the channel in conjunction with amantadine,
would be low, so we excluded Cl<sup>&#x02013;</sup> from the channel
for these studies. Two runs with randomized initial velocity assignments
were performed for each amantadine orientation. Windows were sampled
at 0.25 &#x000c5; intervals from &#x02212;4 to 12 &#x000c5; along the simulation <italic>z</italic> axis for a total of 65 windows. For each trajectory frame,
adamantane center-of-mass positions were extracted and processed with
the weighted histogram analysis program, WHAM,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> for the potential of mean force (PMF) calculation. A convergence
tolerance of 1 &#x000d7; 10<sup>&#x02013;6</sup> and 750 bins were used
to produce the PMF for each channel, orientation, and starting velocity.
After examining the results and finding substantial amantadine orientation
sampling, the PMFs from the four runs, each referenced to its global
minimum, were averaged and then re-referenced to the global minimum
of the average PMF for each channel.</p></sec></sec><sec id="sec3"><title>Results and Discussion</title><sec id="sec3.1"><title>Preliminary
Equilibration</title><p>The number of water molecules
and the root-mean-square deviation (RMSD) in protein atom position
for the set of 13 aforementioned M2 channels from the RCSB Protein
Data Bank were studied (see Table S1 in the <xref rid="notes-1" ref-type="notes">Supporting
Information</xref>). Each channel was placed in DMPC lipid, hydrated,
and allowed to equilibrate. The average amount of water contained
in a sphere spanning protein residues 27&#x02013;41 over the last 2
ns of simulation, the average backbone RMSD of residues 26&#x02013;43
over the last 2 ns of simulation, and snapshot comparisons between
initial PDB structures and structures from final, equilibrated trajectory
frames were determined for each structure (Figure <xref rid="fig1" ref-type="fig">1</xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Averages over the last 2 ns of three 6 ns simulations with light
backbone constraints, here using the CHARMM27 force field. Each M2
channel&#x02019;s (a) average protein-backbone RMSD of residues 26&#x02013;43
from model 1 of its PDB structure, (b) average water content between
residues 27&#x02013;41, and (c) initial/final trajectory frames are
shown. The end-view snapshots of the initial (blue) and final (red)
structures below demonstrate the relative stability of the tilted
helix bundle. Side views better show the variations between PDB models,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> but the end-view was chosen here to demonstrate
the volume of the central cavities.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0001" id="gr1" position="float"/></fig><p>The M2 crystal structure, 3LBW, had the smallest average RMSD when equilibrated
but
had significantly less water content (about 12 lumenal molecules)
than all of the other structures, each of which have over 18 water
molecules in the channel lumen. After filling and equilibrating the
solid-state NMR M2 protein (see Figure S1 in the <xref rid="notes-1" ref-type="notes">Supporting Information</xref>), 2KQT had the next-lowest average RMSD and
water content (about 22 lumenal molecules) more closely matched the
water content of the other structures tested. For these reasons, and
because the M2 structure was determined and refined in liquid crystal
bilayer conditions with amantadine present, 2KQT was used for the
remainder of the study and as the template structure for the creation
of an S31N homology model.</p></sec><sec id="sec3.2"><title>Amantadine Protonation and Orientation</title><p>With neutral
amantadine positioned in the hydrated WT M2, unrestrained dynamics
simulations showed that the amine nitrogen of amantadine flipped between
facing the C-terminus and the N-terminus and back in three out of
five 10.5 ns simulations of WT M2 protein (see Figure S2 in the <xref rid="notes-1" ref-type="notes">Supporting Information</xref>). In contrast, with protonated
amantadine and a Cl<sup>&#x02013;</sup> in the channel, in none of
the five 10.5 ns simulations did the amine nitrogen flip to face the
N-terminus.</p><p>During simulations, the Cl<sup>&#x02013;</sup> generally
stayed near the amine group of amantadine. Apparently, the ionic interaction
between the Cl<sup>&#x02013;</sup> in the channel and the protonated
amino group of amantadine was strong enough to prevent amantadine
from reversing direction and Cl<sup>&#x02013;</sup> from leaving the
channel. When Cl<sup>&#x02013;</sup> was excluded and the amine group
left deprotonated, amantadine was more prone to reverse orientation
toward the N-terminus.</p></sec><sec id="sec3.3"><title>Amantadine Localization: WT vs S31N Channel</title><p>Starting
from the hydrated, equilibrated amantadine<sup>+</sup>-WT and amantadine<sup>+</sup>-S31N systems, unrestrained simulations of 10.5 ns were performed
using NAMD. Adamantane center-of-mass positions were compared from
the simulation trajectories (Figure <xref rid="fig2" ref-type="fig">2</xref>a). In
WT M2 simulations, amantadine stayed relatively stable between 6 and
7.5 &#x000c5; along the <italic>z</italic> axis. In simulations of S31N
M2, amantadine rapidly drifted toward the C-terminus (in some cases
before the end of the heating phase) and, throughout the five separate
simulations, appeared to be less stable, with positions ranging from
2 to 6 &#x000c5; along the <italic>z</italic> axis. Mass-density profiles
of the adamantane amino carbon (C1) averaged over the five simulations
for each channel confirm this result (Figure <xref rid="fig2" ref-type="fig">2</xref>b).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Amantadine positions during five unrestrained simulations of WT
(blue) and S31N (red) M2. (a) Superimposed adamantane center of mass <italic>z</italic>-dimension trajectories for five runs. (b) Carbon mass-density
profile of the adamantane C1 averaged over all five simulations. Black
arrowheads in part b denote the mean &#x003b1;-carbon positions for
Gly34 (left) and Ser/Asn31 (right).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0002" id="gr2" position="float"/></fig><p>The carbon mass-density profile and center-of-mass positions
indicate
significantly different binding-site behavior between WT and S31N
M2 channels in the presence of amantadine. When placed in WT M2, amantadine
stayed very stable within just a few angstroms of the Val27 residues
(Figure <xref rid="fig2" ref-type="fig">2</xref>a and b, blue). However, when placed
in S31N M2, amantadine drifted toward the C-terminus, with greater
diversity between runs and throughout each simulation (Figure <xref rid="fig2" ref-type="fig">2</xref>a and b, red). Thus, it appears that the S31N mutation
alters the binding site of M2, preventing amantadine stability within
the narrower region of the channel between residue positions 27 and
31.</p></sec><sec id="sec3.4"><title>Water Density</title><p>To determine whether drug position affects
the location of water molecules and the potential to form water-wires
for Grotthus transport of protons in M2, linear water densities throughout
all simulations were calculated (Figure <xref rid="fig3" ref-type="fig">3</xref>).</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Water
density, averaged over the five unrestrained simulations
of Figure <xref rid="fig2" ref-type="fig">2</xref>. WT (blue) and S31N (red) M2 channels
with protonated amantadine and Cl<sup>&#x02013;</sup> in the central
cavity. Black arrowheads denote the mean &#x003b1;-carbon positions
for Gly34 (left) and Ser/Asn31 (right).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0003" id="gr3" position="float"/></fig><p>The water-density profiles show that the WT M2 channel has
very
low water density from 4 to 6 &#x000c5; on the <italic>z</italic> axis,
and in S31N M2, significantly more water density is observed in the
same region. Cross-sectional volume-density maps confirm this finding:
WT M2 shows very little water density around and above the drug in
the channel pocket (Figure <xref rid="fig4" ref-type="fig">4</xref>a), where S31N
M2 shows significant water density in this region (Figure <xref rid="fig4" ref-type="fig">4</xref>b).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Amantadine (red) and water (blue) cross-sectional volume
densities
are shown for both (a) WT and (b) S31N M2 channels averaged over five
simulations. Trajectory snapshots of two M2 monomers (green ribbons)
are superimposed, with stick figures for Val27, Ser/Asn31, His37,
and Trp41 side chains from top to bottom, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0004" id="gr4" position="float"/></fig><p>It is also noticeable in Figure <xref rid="fig4" ref-type="fig">4</xref> that the
amantadine density is more distributed in the binding site in the
S31N channel, with only modest density N-ward from the Ser/Asn31 side
chains, in contrast to WT M2. Furthermore, amantadine density appears
to favor one side of the channel, allowing water to fill the available
space laterally. It appears that amantadine is repelled off of the
channel axis by water molecules attracted into the space, as there
are no obvious attractive forces in the walls of the symmetrical channel
that would pull it away from the axis of the channel.</p><p>The difference
in water density is readily observed when visualizing
the trajectories as movies. It is rare to see any water molecules
approach the upper portion of amantadine in WT M2 (see snapshot in
Figure <xref rid="fig5" ref-type="fig">5</xref>a); however, in S31N M2, amantadine
is often oriented in such a way that continuous strands of water can
be observed to form at different times throughout the simulations
(Figure <xref rid="fig5" ref-type="fig">5</xref>b).</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Trajectory snapshots showing water molecules,
two adjacent protein
monomers (with the N- and C-termini arranged from top to bottom, respectively),
and amantadine (shown in red) in (a) WT and (b) S31N M2 systems.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0005" id="gr5" position="float"/></fig><p>The results illustrate that WT
M2 with amantadine present has much
less water density near the Val27 residues or lateral to the amantadine.
S31N M2 has much more water density above amantadine, especially as
it drifts toward the C-terminus, as well as a visible amount of water
density surrounding the drug in all simulations. The region between
Ser/Asn31 and Gly34, according to volume densities and adamantane-cage
position plots, seems to allow for amantadine to be more flexible
in its amine orientation and lateral motion, thus preventing consistent
block of proton conductance.</p></sec><sec id="sec3.5"><title>Umbrella Sampling of WT and S31N Channels</title><p>To investigate
the reasons behind the difference in binding behavior of amantadine
to WT and S31N M2, free energy profiles of amantadine through each
channel were computed via umbrella sampling. The potential of mean
force (PMF) for each channel was calculated by analyzing the position
of the adamantane cage of amantadine, the center of mass of which
was constrained to specific <italic>z</italic> coordinates at 0.25
&#x000c5; intervals, in independent simulations (Figure <xref rid="fig6" ref-type="fig">6</xref>).</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Free energy landscapes of amantadine in WT (blue) and S31N (red)
M2 channels. The free energy minimum of each channel was set to 0
kcal/mol. One standard deviation between runs is shown in dotted lines
of the corresponding color above and below each trace. Gly34 and Ser/Asn31
mean &#x003b1;-carbon positions (black arrowheads) are shown for reference
from left to right, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp-2014-08545d_0006" id="gr6" position="float"/></fig><p>The WT PMF shows deep wells at around 0 and 4 &#x000c5;, with
a broad,
low shelf at around 6 &#x000c5; along the <italic>z</italic> axis. In
contrast, the S31N structure produces a steady decline in the free
energy profile as amantadine moves from the Val27 entryway, followed
by a very steep decline between 6 and 4 &#x000c5;. For the WT, the shelf
at 6 &#x000c5; represents a level energy landscape where amantadine can
dwell with its adamantane center of mass positioned near the Ser31
residues. Here, the adamantane cage is plugged into the Val27 sphincter,
filling the lumen as in the simulations of Figure <xref rid="fig2" ref-type="fig">2</xref>b. The deeper well at 3.5 &#x000c5; indicates a somewhat lower
free energy for amantadine sunk deeper into the central cavity by
a few &#x000c5;. However, the modest difference between the two free
energy levels suggests that the amantadine can frequently and rapidly
return to the blocking position at 6 &#x000c5;. Furthermore, water molecules
below the Ser31 region in WT are more ordered, and are consequently
less likely to be displaced.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> In contrast,
in the S31N construct, the free energy profile would drive amantadine
relentlessly to the deeper region of the central cavity, as observed
in the unconstrained drug simulations above.</p><p>Additional unconstrained
50 ns simulations with amantadine started
at the lower position in WT M2 (and a Cl<sup>&#x02013;</sup> nearby)
also show that amantadine can return to the blocking position at 6
&#x000c5; from the lower free energy well at 3 &#x000c5;. In two out of
five runs, amantadine returned spontaneously to the blocking position
at 6 &#x000c5; within a few ns and remained stable (see Figure S3 in
the <xref rid="notes-1" ref-type="notes">Supporting Information</xref>).</p><p>The
S31N PMF in Figure <xref rid="fig6" ref-type="fig">6</xref> exhibits a sharp
rise in free energy between 4 and 7 &#x000c5;. The plugging site at 6
&#x000c5; is clearly inhospitable compared with deeper positions in the
central cavity, as observed in the unrestrained trajectories. A significant
free energy well at 4 &#x000c5;, with steep barriers on either side,
indicates a strong binding preference for protonated amantadine in
this region. The lack of a shelf or well-defined local minimum for
the adamantane center of mass near the Asn31 residues is a key indicator
of its instability in that region, compared to amantadine in WT M2.</p><p>The forces underlying the steep free energy well inside the S31N
channel need to be further investigated. From the simulations presented
here, it appears likely that attraction of the more polar Asn31 side
chains to water molecules may be the driving force, as well as decreased
stability of amantadine in proximity to the bulkier Asn31 side chains,
as other studies have suggested.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup></p></sec></sec><sec sec-type="conclusions" id="sec4"><title>Conclusions</title><p>Molecular dynamics simulations on the influenza A M2 channels provide
an explanation for why amantadine blocks WT M2 and fails to block
S31N M2, as observed experimentally. Amantadine&#x02019;s stability
and narrow region of occupancy near the V27 sphincter of the M2 channel
appears to result in a very dry region in which proton conductance
by water-wire formation or hydronium-ion diffusion cannot occur. Amantadine&#x02019;s
instability and unusual binding behavior in the S31N M2 channel, as
well as the steep free energy drop between the plugging site and the
deeper noninhibitory binding site, suggest that interactions between
the channel and water molecules drive the drug too deep into the channel.
Hence, in the S31N channel, even if the drug can bind, it cannot block
proton conductance.</p></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>Hydration study table, as well
as figures of 2KQT RMSD and water content, amantadine orientation, and amantadine position
in WT with non-blocking initial position. This material is available
free of charge via the Internet at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jp508545d_si_001.pdf"><caption><p>jp508545d_si_001.pdf</p></caption></media></supplementary-material></sec><notes id="NOTES-d3483e614-autogenerated" notes-type="conflict-of-interest"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors are
grateful to Curtis Evans for several preliminary
simulations and to Antonios Kolocouris and Harris Ioannidis for helpful
discussions. The work was supported by grants from NIH (AI 23007 to
Timothy Cross) and from the BYU Office of Research and Creative Activities.
Simulations and analyses were performed at the Fulton Supercomputing
Lab at Brigham Young University.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Bright</surname><given-names>R. A.</given-names></name>; <name><surname>Shay</surname><given-names>D.</given-names></name>; <name><surname>Bresee</surname><given-names>J.</given-names></name>; <name><surname>Klimov</surname><given-names>A.</given-names></name>; <name><surname>Cox</surname><given-names>N.</given-names></name>; <name><surname>Ortiz</surname><given-names>J.</given-names></name>
<article-title>High Levels of Adamantane
Resistance among Influenza A (H3N2) Viruses
and Interim Guidelines for use of Antiviral Agents. United States,
2005&#x02013;2006 Influenza Season</article-title>. <source>Morbidity
and Mortality Weekly Report</source>
<year>2006</year>, <volume>55</volume>, <fpage>44</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">16424859</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Bright</surname><given-names>R. A.</given-names></name>; <name><surname>Shay</surname><given-names>D. K.</given-names></name>; <name><surname>Shu</surname><given-names>B.</given-names></name>; <name><surname>Cox</surname><given-names>N. J.</given-names></name>; <name><surname>Klimov</surname><given-names>A. I.</given-names></name>
<article-title>Adamantane
Resistance among Influenza A Viruses Isolated Early During the 2005&#x02013;2006
Influenza Season in the United States</article-title>. <source>J. Am.
Med. Assoc.</source>
<year>2006</year>, <volume>295</volume>, <fpage>891</fpage>&#x02013;<lpage>894</lpage>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Sansom</surname><given-names>M. S.</given-names></name>; <name><surname>Kerr</surname><given-names>I. D.</given-names></name>
<article-title>Influenza Virus
M2 Protein: A Molecular Modelling Study
of the Ion Channel</article-title>. <source>Protein Eng.</source>
<year>1993</year>, <volume>6</volume>, <fpage>65</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">7679490</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Voth</surname><given-names>G. A.</given-names></name>
<article-title>A Computational
Study of the Closed and Open States
of the Influenza A M2 Proton Channel</article-title>. <source>Biophys.
J.</source>
<year>2005</year>, <volume>89</volume>, <fpage>2402</fpage>&#x02013;<lpage>2411</lpage>.<pub-id pub-id-type="pmid">16040757</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Mustafa</surname><given-names>M.</given-names></name>; <name><surname>Henderson</surname><given-names>D. J.</given-names></name>; <name><surname>Busath</surname><given-names>D. D.</given-names></name>
<article-title>Free-Energy Profiles for Ions in
the Influenza M2-TMD Channel</article-title>. <source>Proteins</source>
<year>2009</year>, <volume>76</volume>, <fpage>794</fpage>&#x02013;<lpage>807</lpage>.<pub-id pub-id-type="pmid">19296508</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Wei</surname><given-names>C.</given-names></name>; <name><surname>Pohorille</surname><given-names>A.</given-names></name>
<article-title>Activation
and Proton Transport Mechanism in Influenza
A M2 Channel</article-title>. <source>Biophys. J.</source>
<year>2013</year>, <volume>105</volume>, <fpage>2036</fpage>&#x02013;<lpage>2045</lpage>.<pub-id pub-id-type="pmid">24209848</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Fiorin</surname><given-names>G.</given-names></name>; <name><surname>Carnevale</surname><given-names>V.</given-names></name>; <name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Hu</surname><given-names>F.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>; <name><surname>Pinto</surname><given-names>L. H.</given-names></name>; <name><surname>Hong</surname><given-names>M.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>; et al. <article-title>Molecular Dynamics Simulation
Directed Rational Design of Inhibitors
Targeting Drug-Resistant Mutants of Influenza A Virus M2</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume>, <fpage>12834</fpage>&#x02013;<lpage>12841</lpage>.<pub-id pub-id-type="pmid">21744829</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Alhadeff</surname><given-names>R.</given-names></name>; <name><surname>Assa</surname><given-names>D.</given-names></name>; <name><surname>Astrahan</surname><given-names>P.</given-names></name>; <name><surname>Krugliak</surname><given-names>M.</given-names></name>; <name><surname>Arkin</surname><given-names>I. T.</given-names></name>
<article-title>Computational
and Experimental Analysis of Drug Binding to the Influenza M2 Channel</article-title>. <source>Biochim. Biophys. Acta</source>
<year>2014</year>, <volume>1838</volume>, <fpage>1068</fpage>&#x02013;<lpage>1073</lpage>.<pub-id pub-id-type="pmid">24016551</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Qin</surname><given-names>G.</given-names></name>; <name><surname>Yu</surname><given-names>K.</given-names></name>; <name><surname>Shi</surname><given-names>T.</given-names></name>; <name><surname>Luo</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>; <name><surname>Zhu</surname><given-names>W.</given-names></name>; <name><surname>Jiang</surname><given-names>H.</given-names></name>
<article-title>How Does Influenza
Virus A Escape from Amantadine?</article-title>. <source>J. Phys. Chem.
B</source>
<year>2010</year>, <volume>114</volume>, <fpage>8487</fpage>&#x02013;<lpage>8493</lpage>.<pub-id pub-id-type="pmid">20521806</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Khurana</surname><given-names>E.</given-names></name>; <name><surname>Devane</surname><given-names>R. H.</given-names></name>; <name><surname>Dal Peraro</surname><given-names>M.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>
<article-title>Computational Study
of Drug Binding to the Membrane-Bound Tetrameric M2 Peptide Bundle
from Influenza A Virus</article-title>. <source>Biochim. Biophys. Acta</source>
<year>2011</year>, <volume>1808</volume>, <fpage>530</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">20385097</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Leonov</surname><given-names>H.</given-names></name>; <name><surname>Astrahan</surname><given-names>P.</given-names></name>; <name><surname>Krugliak</surname><given-names>M.</given-names></name>; <name><surname>Arkin</surname><given-names>I. T.</given-names></name>
<article-title>How Do Aminoadamantanes
Block the Influenza M2 Channel, and How Does Resistance Develop?</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume>, <fpage>9903</fpage>&#x02013;<lpage>9911</lpage>.<pub-id pub-id-type="pmid">21534619</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Ma</surname><given-names>C.</given-names></name>; <name><surname>Fiorin</surname><given-names>G.</given-names></name>; <name><surname>Pinto</surname><given-names>L. H.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>; <name><surname>Degrado</surname><given-names>W. F.</given-names></name>
<article-title>Structure and Inhibition of the Drug-Resistant
S31N Mutant of the M2 Ion Channel of Influenza A Virus</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2013</year>, <volume>110</volume>, <fpage>1315</fpage>&#x02013;<lpage>1320</lpage>.<pub-id pub-id-type="pmid">23302696</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Gkeka</surname><given-names>P.</given-names></name>; <name><surname>Eleftheratos</surname><given-names>S.</given-names></name>; <name><surname>Kolocouris</surname><given-names>A.</given-names></name>; <name><surname>Cournia</surname><given-names>Z.</given-names></name>
<article-title>Free Energy Calculations
Reveal the Origin of Binding Preference for Aminoadamantane Blockers
of Influenza A/M2TM Pore</article-title>. <source>J. Chem. Theory Comput.</source>
<year>2013</year>, <volume>9</volume>, <fpage>1272</fpage>&#x02013;<lpage>1281</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Kawano</surname><given-names>K.</given-names></name>; <name><surname>Yano</surname><given-names>Y.</given-names></name>; <name><surname>Matsuzaki</surname><given-names>K.</given-names></name>
<article-title>A Dimer Is
the Minimal Proton-Conducting
Unit of the Influenza A Virus M2 Channel</article-title>. <source>J.
Mol. Biol.</source>
<year>2014</year>, <volume>426</volume>, <fpage>2679</fpage>&#x02013;<lpage>2691</lpage>.<pub-id pub-id-type="pmid">24816000</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Salom</surname><given-names>D.</given-names></name>; <name><surname>Hill</surname><given-names>B. R.</given-names></name>; <name><surname>Lear</surname><given-names>J. D.</given-names></name>; <name><surname>DeGrado</surname><given-names>W. F.</given-names></name>
<article-title>Ph-Dependent Tetramerization
and Amantadine Binding of the Transmembrane Helix of M2 from the Influenza
A Virus</article-title>. <source>Biochemistry</source>
<year>2000</year>, <volume>39</volume>, <fpage>14160</fpage>&#x02013;<lpage>14170</lpage>.<pub-id pub-id-type="pmid">11087364</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Acharya</surname><given-names>R.</given-names></name>; <name><surname>Carnevale</surname><given-names>V.</given-names></name>; <name><surname>Fiorin</surname><given-names>G.</given-names></name>; <name><surname>Levine</surname><given-names>B. G.</given-names></name>; <name><surname>Polishchuk</surname><given-names>A. L.</given-names></name>; <name><surname>Balannik</surname><given-names>V.</given-names></name>; <name><surname>Samish</surname><given-names>I.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>; <name><surname>Pinto</surname><given-names>L. H.</given-names></name>; <name><surname>DeGrado</surname><given-names>W. F.</given-names></name>; et al. <article-title>Structure and Mechanism
of Proton Transport
through the Transmembrane Tetrameric M2 Protein Bundle of the Influenza
A Virus</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2010</year>, <volume>107</volume>, <fpage>15075</fpage>&#x02013;<lpage>15080</lpage>.<pub-id pub-id-type="pmid">20689043</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Sakaguchi</surname><given-names>T.</given-names></name>; <name><surname>Tu</surname><given-names>Q.</given-names></name>; <name><surname>Pinto</surname><given-names>L. H.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>
<article-title>The Active Oligomeric State of the
Minimalistic Influenza Virus M2 Ion Channel Is a Tetramer</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>1997</year>, <volume>94</volume>, <fpage>5000</fpage>&#x02013;<lpage>5005</lpage>.<pub-id pub-id-type="pmid">9144179</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Sugrue</surname><given-names>R. J.</given-names></name>; <name><surname>Hay</surname><given-names>A. J.</given-names></name>
<article-title>Structural Characteristics of the
M2 Protein of Influenza
A Viruses: Evidence That It Forms a Tetrameric Channel</article-title>. <source>Virology</source>
<year>1991</year>, <volume>180</volume>, <fpage>617</fpage>&#x02013;<lpage>624</lpage>.<pub-id pub-id-type="pmid">1989386</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Holsinger</surname><given-names>L. J.</given-names></name>; <name><surname>Lamb</surname><given-names>R. A.</given-names></name>
<article-title>Influenza Virus M2 Integral Membrane Protein Is a Homotetramer
Stabilized by Formation of Disulfide Bonds</article-title>. <source>Virology</source>
<year>1991</year>, <volume>183</volume>, <fpage>32</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">2053285</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Jorgensen</surname><given-names>W. L.</given-names></name>; <name><surname>Chandrasekhar</surname><given-names>J.</given-names></name>; <name><surname>Madura</surname><given-names>J. D.</given-names></name>; <name><surname>Impey</surname><given-names>R. W.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>
<article-title>Comparison
of Simple Potential Functions for Simulating Liquid Water</article-title>. <source>J. Chem. Phys.</source>
<year>1983</year>, <volume>79</volume>, <fpage>926</fpage>&#x02013;<lpage>935</lpage>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Brooks</surname><given-names>B. R.</given-names></name>; <name><surname>Brooks</surname><given-names>C. L.</given-names><suffix>3rd</suffix></name>; <name><surname>Mackerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>; <name><surname>Nilsson</surname><given-names>L.</given-names></name>; <name><surname>Petrella</surname><given-names>R. J.</given-names></name>; <name><surname>Roux</surname><given-names>B.</given-names></name>; <name><surname>Won</surname><given-names>Y.</given-names></name>; <name><surname>Archontis</surname><given-names>G.</given-names></name>; <name><surname>Bartels</surname><given-names>C.</given-names></name>; <name><surname>Boresch</surname><given-names>S.</given-names></name>; et al. <article-title>CHARMM:
The Biomolecular Simulation Program</article-title>. <source>J. Comput.
Chem.</source>
<year>2009</year>, <volume>30</volume>, <fpage>1545</fpage>&#x02013;<lpage>1614</lpage>.<pub-id pub-id-type="pmid">19444816</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Phillips</surname><given-names>J.
C.</given-names></name>; <name><surname>Braun</surname><given-names>R.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Gumbart</surname><given-names>J.</given-names></name>; <name><surname>Tajkhorshid</surname><given-names>E.</given-names></name>; <name><surname>Villa</surname><given-names>E.</given-names></name>; <name><surname>Chipot</surname><given-names>C.</given-names></name>; <name><surname>Skeel</surname><given-names>R. D.</given-names></name>; <name><surname>Kal&#x000e9;</surname><given-names>L.</given-names></name>; <name><surname>Schulten</surname><given-names>K.</given-names></name>
<article-title>Scalable Molecular Dynamics with NAMD</article-title>. <source>J. Comput. Chem.</source>
<year>2005</year>, <volume>26</volume>, <fpage>1781</fpage>&#x02013;<lpage>1802</lpage>.<pub-id pub-id-type="pmid">16222654</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><person-group><name><surname>Humphrey</surname><given-names>W.</given-names></name>; <name><surname>Dalke</surname><given-names>A.</given-names></name>; <name><surname>Schulten</surname><given-names>K.</given-names></name></person-group><article-title>Vmd:
Visual Molecular Dynamics</article-title>. <source>J. Mol. Graphics</source><year>1996</year>, <volume>14</volume>, <fpage>33-8, 27-8</fpage>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>MacKerell</surname><given-names>A. D.</given-names></name>; <name><surname>Bashford</surname><given-names>D.</given-names></name>; <name><surname>Bellott</surname></name>; <name><surname>Dunbrack</surname><given-names>R. L.</given-names></name>; <name><surname>Evanseck</surname><given-names>J. D.</given-names></name>; <name><surname>Field</surname><given-names>M. J.</given-names></name>; <name><surname>Fischer</surname><given-names>S.</given-names></name>; <name><surname>Gao</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>H.</given-names></name>; <name><surname>Ha</surname><given-names>S.</given-names></name>; et al. <article-title>All-Atom Empirical Potential for Molecular Modeling
and Dynamics
Studies of Proteins</article-title>. <source>J. Phys. Chem. B</source>
<year>1998</year>, <volume>102</volume>, <fpage>3586</fpage>&#x02013;<lpage>3616</lpage>.<pub-id pub-id-type="pmid">24889800</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Mackerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>; <name><surname>Feig</surname><given-names>M.</given-names></name>; <name><surname>Brooks</surname><given-names>C. L.</given-names><suffix>3rd</suffix></name>
<article-title>Extending the Treatment of Backbone
Energetics in Protein Force Fields:
Limitations of Gas-Phase Quantum Mechanics in Reproducing Protein
Conformational Distributions in Molecular Dynamics Simulations</article-title>. <source>J. Comput. Chem.</source>
<year>2004</year>, <volume>25</volume>, <fpage>1400</fpage>&#x02013;<lpage>1415</lpage>.<pub-id pub-id-type="pmid">15185334</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="book" id="cit26"><person-group person-group-type="allauthors"><name><surname>Merz</surname><given-names>K. M.</given-names></name>; <name><surname>Roux</surname><given-names>B.</given-names></name></person-group><source>Biological Membranes:
A Molecular Perspective from Computation and Experiment</source>; <publisher-name>Birkh&#x000e4;user</publisher-name>: <publisher-loc>Boston, MA</publisher-loc>, <year>1996</year>.</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Feller</surname><given-names>S.
E.</given-names></name>; <name><surname>Yin</surname><given-names>D.</given-names></name>; <name><surname>Pastor</surname><given-names>R. W.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>
<article-title>Molecular Dynamics
Simulation of Unsaturated Lipid Bilayers at Low Hydration: Parameterization
and Comparison with Diffraction Studies</article-title>. <source>Biophys.
J.</source>
<year>1997</year>, <volume>73</volume>, <fpage>2269</fpage>&#x02013;<lpage>2279</lpage>.<pub-id pub-id-type="pmid">9370424</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Klauda</surname><given-names>J.
B.</given-names></name>; <name><surname>Venable</surname><given-names>R. M.</given-names></name>; <name><surname>Freites</surname><given-names>J. A.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>J. W.</given-names></name>; <name><surname>Tobias</surname><given-names>D. J.</given-names></name>; <name><surname>Mondragon-Ramirez</surname><given-names>C.</given-names></name>; <name><surname>Vorobyov</surname><given-names>I.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names></name>; <name><surname>Pastor</surname><given-names>R. W.</given-names></name>
<article-title>Update of the CHARMM
All-Atom Additive Force Field
for Lipids: Validation on Six Lipid Types</article-title>. <source>J.
Phys. Chem. B</source>
<year>2010</year>, <volume>114</volume>, <fpage>7830</fpage>&#x02013;<lpage>7843</lpage>.<pub-id pub-id-type="pmid">20496934</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Fu</surname><given-names>R.</given-names></name>; <name><surname>Nishimura</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>H.-X.</given-names></name>; <name><surname>Busath</surname><given-names>D. D.</given-names></name>; <name><surname>Vijayvergiya</surname><given-names>V.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>Histidines, Heart of the Hydrogen
Ion Channel from Influenza A Virus: Toward an Understanding of Conductance
and Proton Selectivity</article-title>. <source>Proc. Natl. Acad. Sci.
U. S. A.</source>
<year>2006</year>, <volume>103</volume>, <fpage>6865</fpage>&#x02013;<lpage>6870</lpage>.<pub-id pub-id-type="pmid">16632600</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Williams</surname><given-names>J.
K.</given-names></name>; <name><surname>Tietze</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>DeGrado</surname><given-names>W. F.</given-names></name>; <name><surname>Hong</surname><given-names>M.</given-names></name>
<article-title>Drug-Induced
Conformational and Dynamical Changes of the S31N Mutant
of the Influenza M2 Proton Channel Investigated by Solid-State NMR</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume>, <fpage>9885</fpage>&#x02013;<lpage>9897</lpage>.<pub-id pub-id-type="pmid">23758317</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Yi</surname><given-names>M.</given-names></name>; <name><surname>Dong</surname><given-names>H.</given-names></name>; <name><surname>Qin</surname><given-names>H.</given-names></name>; <name><surname>Peterson</surname><given-names>E.</given-names></name>; <name><surname>Busath</surname><given-names>D. D.</given-names></name>; <name><surname>Zhou</surname><given-names>H.-X.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>Insight into the Mechanism of the
Influenza A Proton Channel from a Structure in a Lipid Bilayer</article-title>. <source>Science</source>
<year>2010</year>, <volume>330</volume>, <fpage>509</fpage>&#x02013;<lpage>512</lpage>.<pub-id pub-id-type="pmid">20966252</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Busath</surname><given-names>D. D.</given-names></name>; <name><surname>Zhou</surname><given-names>H. X.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>Drug Sensitivity,
Drug-Resistant Mutations, and Structures of Three Conductance Domains
of Viral Porins</article-title>. <source>Biochim. Biophys. Acta</source>
<year>2011</year>, <volume>1808</volume>, <fpage>538</fpage>&#x02013;<lpage>546</lpage>.<pub-id pub-id-type="pmid">20655872</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Martyna</surname><given-names>G. J.</given-names></name>; <name><surname>Tobias</surname><given-names>D. J.</given-names></name>; <name><surname>Klein</surname><given-names>M. L.</given-names></name>
<article-title>Constant
Pressure Molecular Dynamics
Algorithms</article-title>. <source>J. Chem. Phys.</source>
<year>1994</year>, <volume>101</volume>, <fpage>4177</fpage>&#x02013;<lpage>4189</lpage>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Feller</surname><given-names>S. E.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Pastor</surname><given-names>R. W.</given-names></name>; <name><surname>Brooks</surname><given-names>B. R.</given-names></name>
<article-title>Constant
Pressure
Molecular Dynamics Simulation: The Langevin Piston Method</article-title>. <source>J. Chem. Phys.</source>
<year>1995</year>, <volume>103</volume>, <fpage>4613</fpage>&#x02013;<lpage>4621</lpage>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Essmann</surname><given-names>U.</given-names></name>; <name><surname>Perera</surname><given-names>L.</given-names></name>; <name><surname>Berkowitz</surname><given-names>M. L.</given-names></name>; <name><surname>Darden</surname><given-names>T.</given-names></name>; <name><surname>Lee</surname><given-names>H.</given-names></name>; <name><surname>Pedersen</surname><given-names>L. G.</given-names></name>; <name><surname>Smooth</surname><given-names>A.</given-names></name>
<article-title>Particle Mesh Ewald Method</article-title>. <source>J. Chem. Phys.</source>
<year>1995</year>, <volume>103</volume>, <fpage>8577</fpage>&#x02013;<lpage>8593</lpage>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Ryckaert</surname><given-names>J.-P.</given-names></name>; <name><surname>Ciccotti</surname><given-names>G.</given-names></name>; <name><surname>Berendsen</surname><given-names>H. J. C.</given-names></name>
<article-title>Numerical Integration of the Cartesian
Equations of Motion of a System with Constraints: Molecular Dynamics
of N-Alkanes</article-title>. <source>J. Comput. Phys.</source>
<year>1977</year>, <volume>23</volume>, <fpage>327</fpage>&#x02013;<lpage>341</lpage>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Nishimura</surname><given-names>K.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>The Closed State of a H<sup>+</sup> Channel Helical
Bundle Combining Precise Orientational and Distance
Restraints from Solid State NMR</article-title>. <source>Biochemistry</source>
<year>2002</year>, <volume>41</volume>, <fpage>13170</fpage>&#x02013;<lpage>13177</lpage>.<pub-id pub-id-type="pmid">12403618</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Asbury</surname><given-names>T.</given-names></name>; <name><surname>Achuthan</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Bertram</surname><given-names>R.</given-names></name>; <name><surname>Quine</surname><given-names>J. R.</given-names></name>; <name><surname>Fu</surname><given-names>R.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>Backbone
Structure
of the Amantadine-Blocked Trans-Membrane Domain M2 Proton Channel
from Influenza A Virus</article-title>. <source>Biophys. J.</source>
<year>2007</year>, <volume>92</volume>, <fpage>4335</fpage>&#x02013;<lpage>4343</lpage>.<pub-id pub-id-type="pmid">17384070</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Cady</surname><given-names>S. D.</given-names></name>; <name><surname>Mishanina</surname><given-names>T. V.</given-names></name>; <name><surname>Hong</surname><given-names>M.</given-names></name>
<article-title>Structure of Amantadine-Bound M2
Transmembrane Peptide of Influenza A in Lipid Bilayers from Magic-Angle-Spinning
Solid-State NMR: The Role of Ser31 in Amantadine Binding</article-title>. <source>J. Mol. Biol.</source>
<year>2009</year>, <volume>385</volume>, <fpage>1127</fpage>&#x02013;<lpage>1141</lpage>.<pub-id pub-id-type="pmid">19061899</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Pielak</surname><given-names>R. M.</given-names></name>; <name><surname>Schnell</surname><given-names>J. R.</given-names></name>; <name><surname>Chou</surname><given-names>J. J.</given-names></name>
<article-title>Mechanism of Drug Inhibition and
Drug Resistance of Influenza A M2 Channel</article-title>. <source>Proc.
Natl. Acad. Sci. U. S. A.</source>
<year>2009</year>, <volume>106</volume>, <fpage>7379</fpage>&#x02013;<lpage>7384</lpage>.<pub-id pub-id-type="pmid">19383794</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Pielak</surname><given-names>R. M.</given-names></name>; <name><surname>McClintock</surname><given-names>M. A.</given-names></name>; <name><surname>Chou</surname><given-names>J. J.</given-names></name>
<article-title>Solution Structure
and Functional Analysis of the Influenza B Proton Channel</article-title>. <source>Nat. Struct. Mol. Biol.</source>
<year>2009</year>, <volume>16</volume>, <fpage>1267</fpage>&#x02013;<lpage>1271</lpage>.<pub-id pub-id-type="pmid">19898475</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Cady</surname><given-names>S. D.</given-names></name>; <name><surname>Schmidt-Rohr</surname><given-names>K.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Soto</surname><given-names>C. S.</given-names></name>; <name><surname>Degrado</surname><given-names>W. F.</given-names></name>; <name><surname>Hong</surname><given-names>M.</given-names></name>
<article-title>Structure of the Amantadine Binding Site of Influenza M2 Proton Channels
in Lipid Bilayers</article-title>. <source>Nature</source>
<year>2010</year>, <volume>463</volume>, <fpage>689</fpage>&#x02013;<lpage>692</lpage>.<pub-id pub-id-type="pmid">20130653</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Pielak</surname><given-names>R. M.</given-names></name>; <name><surname>Chou</surname><given-names>J. J.</given-names></name>
<article-title>Solution NMR Structure of the V27A
Drug Resistant Mutant
of Influenza A M2 Channel</article-title>. <source>Biochem. Biophys.
Res. Commun.</source>
<year>2010</year>, <volume>401</volume>, <fpage>58</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">20833142</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Pielak</surname><given-names>R.
M.</given-names></name>; <name><surname>Oxenoid</surname><given-names>K.</given-names></name>; <name><surname>Chou</surname><given-names>J. J.</given-names></name>
<article-title>Structural Investigation of Rimantadine
Inhibition of the AM2-BM2 Chimera Channel of Influenza Viruses</article-title>. <source>Structure</source>
<year>2011</year>, <volume>19</volume>, <fpage>1655</fpage>&#x02013;<lpage>1663</lpage>.<pub-id pub-id-type="pmid">22078564</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Schnell</surname><given-names>J. R.</given-names></name>; <name><surname>Chou</surname><given-names>J. J.</given-names></name>
<article-title>Structure and Mechanism of the M2 Proton Channel of
Influenza A Virus</article-title>. <source>Nature</source>
<year>2008</year>, <volume>451</volume>, <fpage>591</fpage>&#x02013;<lpage>595</lpage>.<pub-id pub-id-type="pmid">18235503</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Guex</surname><given-names>N.</given-names></name>; <name><surname>Peitsch</surname><given-names>M. C.</given-names></name>
<article-title>Swiss-Model and the Swiss-PDBViewer:
An Environment
for Comparative Protein Modeling</article-title>. <source>Electrophoresis</source>
<year>1997</year>, <volume>18</volume>, <fpage>2714</fpage>&#x02013;<lpage>2723</lpage>.<pub-id pub-id-type="pmid">9504803</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Schwede</surname><given-names>T.</given-names></name>; <name><surname>Kopp</surname><given-names>J.</given-names></name>; <name><surname>Guex</surname><given-names>N.</given-names></name>; <name><surname>Peitsch</surname><given-names>M. C.</given-names></name>
<article-title>Swiss-Model: An
Automated Protein Homology-Modeling Server</article-title>. <source>Nucleic Acids Res.</source>
<year>2003</year>, <volume>31</volume>, <fpage>3381</fpage>&#x02013;<lpage>3385</lpage>.<pub-id pub-id-type="pmid">12824332</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Vanommeslaeghe</surname><given-names>K.</given-names></name>; <name><surname>Hatcher</surname><given-names>E.</given-names></name>; <name><surname>Acharya</surname><given-names>C.</given-names></name>; <name><surname>Kundu</surname><given-names>S.</given-names></name>; <name><surname>Zhong</surname><given-names>S.</given-names></name>; <name><surname>Shim</surname><given-names>J.</given-names></name>; <name><surname>Darian</surname><given-names>E.</given-names></name>; <name><surname>Guvench</surname><given-names>O.</given-names></name>; <name><surname>Lopes</surname><given-names>P.</given-names></name>; <name><surname>Vorobyov</surname><given-names>I.</given-names></name>; et al. <article-title>CHARMM General Force Field: A Force Field for
Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological
Force Fields</article-title>. <source>J. Comput. Chem.</source>
<year>2010</year>, <volume>31</volume>, <fpage>671</fpage>&#x02013;<lpage>690</lpage>.<pub-id pub-id-type="pmid">19575467</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Yu</surname><given-names>W.</given-names></name>; <name><surname>He</surname><given-names>X.</given-names></name>; <name><surname>Vanommeslaeghe</surname><given-names>K.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>
<article-title>Extension of the CHARMM General Force
Field to Sulfonyl-Containing
Compounds and Its Utility in Biomolecular Simulations</article-title>. <source>J. Comput. Chem.</source>
<year>2012</year>, <volume>33</volume>, <fpage>2451</fpage>&#x02013;<lpage>2468</lpage>.<pub-id pub-id-type="pmid">22821581</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Vanommeslaeghe</surname><given-names>K.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>
<article-title>Automation of the CHARMM General
Force Field (CGenFF) II: Bond Perception and Atom Typing</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2012</year>, <volume>52</volume>, <fpage>3144</fpage>&#x02013;<lpage>3154</lpage>.<pub-id pub-id-type="pmid">23146088</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Vanommeslaeghe</surname><given-names>K.</given-names></name>; <name><surname>Raman</surname><given-names>E. P.</given-names></name>; <name><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr.</suffix></name>
<article-title>Automation of
the Charmm General Force Field (Cgenff) Ii: Assignment of Bonded Parameters
and Partial Atomic Charges</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2012</year>, <volume>52</volume>, <fpage>3155</fpage>&#x02013;<lpage>3168</lpage>.<pub-id pub-id-type="pmid">23145473</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Cady</surname><given-names>S. D.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>DeGrado</surname><given-names>W. F.</given-names></name>; <name><surname>Hong</surname><given-names>M.</given-names></name>
<article-title>Specific Binding
of Adamantane Drugs and Direction of Their Polar Amines in the Pore
of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine
Micelles Determined by NMR Spectroscopy</article-title>. <source>J.
Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume>, <fpage>4274</fpage>&#x02013;<lpage>4284</lpage>.<pub-id pub-id-type="pmid">21381693</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Giorgino</surname><given-names>T.</given-names></name>
<article-title>Computing
1-D Atomic Densities in Macromolecular Simulations: The Density Profile
Tool for VMD</article-title>. <source>Comput. Phys. Commun.</source>
<year>2014</year>, <volume>185</volume>, <fpage>317</fpage>&#x02013;<lpage>322</lpage>.</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="book" id="cit54"><person-group person-group-type="allauthors"><name><surname>Allen</surname><given-names>P.</given-names></name>; <name><surname>Tildesley</surname><given-names>D. J.</given-names></name></person-group><source>Computer
Simulation
of Liquids</source>; <publisher-name>Clarendon Press</publisher-name>: <publisher-loc>Oxford, U.K.</publisher-loc>, <year>1989</year>.</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="computer-program" id="cit55"><person-group person-group-type="allauthors"><name><surname>Grossfield</surname><given-names>A.</given-names></name></person-group><source>Wham: The
Weighted Histogram Analysis Method</source>, 2.0.9. Available: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://membrane.urmc.rochester.edu/content/wham">http://membrane.urmc.rochester.edu/content/wham</uri>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Zhou</surname><given-names>H. X.</given-names></name>; <name><surname>Cross</surname><given-names>T. A.</given-names></name>
<article-title>Modeling the Membrane Environment Has Implications
for Membrane Protein Structure and Function: Influenza A M2 Protein</article-title>. <source>Protein Sci.</source>
<year>2013</year>, <volume>22</volume>, <fpage>381</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">23389890</pub-id></mixed-citation></ref></ref-list></back></article>